Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro

European Journal of Cancer Prevention

Volumn 20, Issue 1, 2011, Pages 9-17

  Ling, Yu Xiao ^a   Tao, Jing ^b   Fang, Shang F ^c   Hui, Zhao ^a   Fang, Qi R ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b QINGDAO UNIVERSITY   (China)

^c 401st Hospital of Chinese People's Liberation Army   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; GELATINASE A; INHIBITOR OF DIFFERENTIATION 1; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BELGIUM; CANCER CELL CULTURE; CANCER INHIBITION; CELL AGING; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE INACTIVATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; INJECTIONS, INTRALESIONAL; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 78650515957     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833ebaa0     Document Type: Article

References (33)

1. Asirvatham AJ, Schmidt MA, Chaudhary J (2006). Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells. The Prostate 66:921-935.
2. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H (1990). The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
3. Benezra R, Rafii S, Lyden D (2001). The Id proteins and angiogenesis. Oncogene 20:8334-8341.
4. Chatenoud L, Bertuccio P, Bosetti C, Levi F, Curado MP, Malvezzi M, et al. (2010). Trends in cancer mortality in Brazil, 1980-2004. Eur J Cancer Prev 19:79-86.
5. Cormick D, Hall PA (1992). The complexities of proliferating cell nuclear antigen. Histopathology 21:591-594.
6. Cummings SD, Ryu B, Samuels MA, Yu X, Meeker AK, Healey MA, et al. (2008). Id1 delays senescence of primary human melanocytes. Mol Carcinog 47:653-659.
7. De Candia P, Benera R, Solit DB (2004). A role for Id proteins in mammary gland physiology and tumorigenesis. Adv Cancer Res 92:81-94.
8. De Cicco C, Ravasi L, Zorzino L, Sandri MT, Botteri E, Verweij F, et al. (2008). Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancer. Curr Cancer Drug Targets 8:199-206.
9. Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ, Campisi J (1998). A novel pathway for mammary epithelial cell invasion induced by the helix-loophelix protein Id-1. Mol Cell Biol 18:4577-4588.
10. Di K, Ling MT, Tsao SW, Wong YC, Wang X (2006). Id-1 modulates senescence and TGF-beta1 sensitivity in prostate epithelial cells. Biol Cell 98:523-533.
11. Dos Reis ST, Pontes J Jr, Villanova FE, Borra PM, Antunes AA, Dall'oglio MF, et al. (2009). Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. J Urol 181:2320-2325.
12. Dunn BK, Ford LG (2007). Hormonal interventions to prevent hormonal cancers: Breast and prostate cancers. Eur J Cancer Prev 16:232-242.
13. Fong S, Itahana Y, Sumida T, Singh J, Coppe JP, Liu Y, et al. (2003). Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 100:13543-13548.
14. Han S, Guo C, Hong L, Liu J, ZheyiHan, Liu C, et al. (2004). Expression and significance of Id1 helix-loop-helix protein overexpression in gastric cancer. Cancer Lett 216:63-71.
15. Jang KS, Han HX, Paik SS, Brown PH, Kong G (2006). Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Cancer Lett 244:203-210.
16. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007). Cancer statistics, 2007. CA Cancer J Clin 57:43-66.
17. Ling MT,Wang X, Ouyang XS, Xu K, Tsao SW,Wong YC (2003). Id-1 expression promotes cell survival through activation of NF-kB signaling pathway in prostate cancer cells. Oncogene 22:4498-4508.
18. Ling MT, Wang X, Lee DT, Tam PC, Tsao SW, Wong YC (2004). Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). Carcinogenesis 25:517-525.
19. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
20. Matsuda Y, Yamagiwa S, Takamura M, Honda Y, Ishimoto Y, Ichida T, et al. (2005). Overexpressed Id-1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16. Cancer 104:1037-1044.
21. Ouyang XS, Wang X, Lee DT, Tsao SW, Wong YC (2002). Overexpression of D-1 in prostate cancer. J Urol 167:2598-2602.
22. Perk J, Iavarone A, Benezra R (2005). Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5:603-614.
23. Schindl M, Schoppmann SF, Strobel T, Heinzl H, Leisser C, Horvat R, et al. (2003). Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res 9:779-785.
24. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, et al. (2003). Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer 104:677-682.
25. Straume O, Akslen LA (2005). Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma. Br J Cancer 93:933-938.
26. Swarbrick A, Roy E, Allen T, Bishop JM (2008). Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc Natl Acad Sci U S A 105: 5402-5407.
27. Tangney M, Ahmad S, Collins SA, O'Sullivan GC (2010). Gene therapy for prostate cancer. Postgrad Med 122:166-180.
28. Tsuchiya T, Okaji Y, Tsuno NH, Sakurai D, Tsuchiya N, Kawai K, et al. (2005). Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. Cancer Sci 96:784-790.
29. Ying QL, Nichols J, Chambers I, Smith A (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115:281-292.
30. Yu X, Xu X, Han B, Zhou R (2009). Inhibitor of DNA binding-1 overexpression in prostate cancer: Relevance to tumor differentiation. Pathol Oncol Res 15:91-96.
31. Zebedee Z, Hara E (2001). Id proteins in cell cycle control and cellular senescence. Oncogene 20:8317-8325.
32. Zhang X, Ling MT,Wang X,Wong YC (2006). Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway. Int J Cancer 118:2072-2081.
33. Zhong W, Peng J, He H, Wu D, Han Z, Bi X, et al. (2008). Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. Clin Invest Med 31:8-15.